8th Annual Mood Disorders Summit

8th Annual Mood Disorders Summit (Two-day Program – Fri.-Sat., Sept. 10-11, 2021)


Webinar -- 10:00 AM ET
https://www.clinicaloptions.com/MoodDisordersNEU2021Join1

Agenda

Tentative Agenda for the Two-Day Program
(subject to change) 

Day 1 - Friday, September 10, 2021

9:45 – 10:00 AM: Opening Remarks – Roger McIntyre, MD, Chair

10:00 – 11:00 AM: Keynote address:  Psychedelics in Psychiatry: Has Their Time Come? – Guy Goodwin, MD

11:00 – 12:00 PM: Symptom-specific Efficacy of Treatments for Depression: Recent Findings – Pim Cuijpers, PhD
-5 min break- 

12:05 – 1:05 PM: Non-CME Educational Talk 1
-25 min lunch break- 

1:30 – 2:30 PM: Current Controversies in Mood Disorders, Part I – Sanjay Mathew, MD
-5 min break- 

2:35 – 3:35 PM: Non-CME Educational Talk 2
-15 min break 

3:50 – 4:50 PM: Mood Disorders and TD: An Intricate Relationship – Greg Mattingly, MD
-5 min break-

4:55 – 5:55 PM: Non-CME Educational Talk 3
-5 min break- 

6:00 – 7:00 PM: Assessing Mental Health Apps in the Marketplace: What Should Clinicians Know – John Torous, MD

7:00 – 7:05 PM: Closing Remarks – Roger McIntyre, MD, Chair

 

Day 2 - Saturday, September 11, 2021

9:45 – 10:00 AM: Opening Remarks – Roger McIntyre, MD, Chair

10:00 – 11:00 AM: Implementing Measurement-Based Care in the Management of Psychiatric Illness – Kurt Kroenke, MD

11:00 – 12:00 PM: Managing Treatment Resistant Depression: A Global Perspective – Siegfried Kasper MD
-5 min break- 

12:05 – 1:05 PM: Non-CME Educational Talk 4
-25 min lunch break- 

1:30 – 2:30 PM: Managing the Bipolar Depressive Spectrum: How Wide is the Spectrum? – Roger McIntyre, MD
-5 min break- 

2:35 – 3:35 PM: Non-CME Educational Talk 5
-15 min break-

3:50 – 4:50 PM: Role of Inflammation in the Etiology, Diagnosis and Treatment of Mood Disorders – Jennifer Felger, MD

4:50 – 5:50 PM: Current Controversies in Mood Disorders, Part II – Joseph Goldberg, MD

5:50 – 6:00 PM: Closing Remarks – Roger McIntyre, MD, Chair

Faculty

Faculty
Pim Cuijpers, PhD

Professor of Clinical Psychology
Vrije Universiteit Amsterdam (The Netherlands)

Faculty
Jennifer Felger, PhD, MSc

Associate Professor
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

Faculty
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine, Mount Sinai
New York, New York

Faculty
Guy Goodwin, FMedSci

Emeritus Professor
Department of Psychiatry
University of Oxford
Oxford, United Kingdom

Faculty
Siegfried Kasper, MD

Professor of Psychiatry
Chairman, 
Department of Psychiatry and Psychotherapy
Medical University of Vienna
Vienna, Austria

Faculty
Kurt Kroenke, MD

Professor of Medicine
Indiana University School of Medicine
Scientist
Regenstrief Institute
Indianapolis, Indiana

Faculty
Sanjay J. Mathew, MD

Professor and Vice Chair for Research
Psychiatry and Behavioral Sciences
Baylor College of Medicine
Houston, Texas

Faculty
Greg Mattingly, MD

Associate Clinical Professor
Washington University School of Medicine
St. Louis, Missouri

Faculty
Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada

Faculty
John Torous, MD

Assistant Professor of Psychiatry
Division of Digital Psychiatry
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of mood disorders.

Target Audience
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with mood disorders.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify current controversies in mood disorders
  • Describe the role for mental health apps in psychiatry
  • Manage TD in patients with mood disorders
  • Employ evidence-based treatments for bipolar depression including treatment-resistant patients
  • Describe the role of inflammation in mood disorders
  • Describe the latest research on psychedelics in mood disorders
  • Utilize the latest evidence-based treatments for resistant depression
  • Employ measurement-based care in mood disorders

Accreditation

*Credits/Contact Hours are subject to change

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 10 AMA PRA Category 1 CreditsTM. Psysicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 10.0 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 10.0 contact hours (1.0 CEUs) of the Accreditation Council for Pharmacy Education. UAN will be specific to each topic.

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 10.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC (CCO) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CCO maintains responsibility for this course. Social workers completing this course will receive up to 10.0 continuing education credits.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.